![Letter by Tampakis et al Regarding Article, “Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease”]()
Letter by Tampakis et al Regarding Article, “Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease”Tampakis, Athanasios; Tampaki, Ekaterini Christina; Gürke, Lorenz · Circulation · 2018